Classification of Patients With GH Disorders May Vary According to the IGF-I Assay

Abstract : Context: Insulinlike growth factor I (IGF-I) measurement is essential for the diagnosis and management of growth hormone (GH) disorders. However, patient classification may vary substantially according to the assay technique. Objective: We compared individual patient data and classifications obtained with six different IGF-I assay kits in a group of patients with various GH disorders. Design: In this cross-sectional study, we measured IGF-I with six immunoassays in 102 patients with active or treated acromegaly or GH deficiency. IGF-I normative data previously established for the same six assay kits were used to classify the patients (high, low, or normal IGF-I levels), using both raw data and standard deviation scores (SDSs). Pairwise concordance between assays was assessed with Bland-Altman plots and with the percentage of observed agreement and the weighted κ coefficient for categorized IGF-I SDS. Results: We observed marked variability both across each individual's IGF-I raw data and across IGF-I SDS values obtained with each of the six immunoassays. Pairwise concordance between assay values, as assessed with the weighted κ coefficient, ranged from 0.50 (moderate) to 0.81 (excellent). Conclusion: Even when using normative data obtained in the same large population of healthy subjects and when using calculated IGF-I SDSs, agreement among IGF-I assay methods is only moderate to good. Differences in assay performance must be taken into account when evaluating and monitoring patients with GH disorders. This argues for the use of the same IGF-I assay for a given patient throughout follow-up.
Type de document :
Article dans une revue
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2017, 102 (8), pp.2844-2852. 〈10.1210/jc.2017-00202〉
Liste complète des métadonnées

Littérature citée [19 références]  Voir  Masquer  Télécharger

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01579404
Contributeur : Laurent Jonchère <>
Soumis le : vendredi 10 novembre 2017 - 14:06:07
Dernière modification le : lundi 13 novembre 2017 - 14:48:36

Identifiants

Citation

Maria Mavromati, Emmanuelle Kuhn, Hélène Agostini, Sylvie Brailly-Tabard, Catherine Massart, et al.. Classification of Patients With GH Disorders May Vary According to the IGF-I Assay. Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2017, 102 (8), pp.2844-2852. 〈10.1210/jc.2017-00202〉. 〈hal-01579404〉

Partager

Métriques

Consultations de la notice

30

Téléchargements de fichiers

4